Pitfalls in HLA Ligandomics-How to Catch a Li(e)gand
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 20, 100110
- https://doi.org/10.1016/j.mcpro.2021.100110
Abstract
No abstract availableFunding Information
- Cancer Prevention and Research Institute of Texas (DP150029)
This publication has 37 references indexed in Scilit:
- Targeted Quantitation of Proteins by Mass SpectrometryBiochemistry, 2013
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Two Sample Logo: a graphical representation of the differences between two sets of sequence alignmentsBioinformatics, 2006
- Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA moleculesEuropean Journal of Immunology, 1995
- p53, a potential target for tumor-directed T cellsImmunology Letters, 1994
- Incomplete Fmoc deprotection in solid‐phase synthesis of peptidesInternational Journal of Peptide and Protein Research, 1994
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992
- Proteases and proteolysis in the lysosomeCellular and Molecular Life Sciences, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Prediction of difficult sequences in solid-phase peptide synthesisJournal of the American Chemical Society, 1990